Egypt
· Delayed Price · Currency is EGP AMES Statistics
Total Valuation
Alexandria New Medical Center has a market cap or net worth of EGP 2.61 billion. The enterprise value is 2.57 billion.
| Market Cap | 2.61B |
| Enterprise Value | 2.57B |
Important Dates
The last earnings date was Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Alexandria New Medical Center has 124.58 million shares outstanding. The number of shares has decreased by -5.61% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 124.58M |
| Shares Change (YoY) | -5.61% |
| Shares Change (QoQ) | -3.98% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.87M |
Valuation Ratios
The trailing PE ratio is 195.43.
| PE Ratio | 195.43 |
| Forward PE | n/a |
| PS Ratio | 7.89 |
| PB Ratio | 11.80 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 98.79, with an EV/FCF ratio of -390.76.
| EV / Earnings | 197.52 |
| EV / Sales | 7.97 |
| EV / EBITDA | 98.79 |
| EV / EBIT | 166.41 |
| EV / FCF | -390.76 |
Financial Position
The company has a current ratio of 1.51
| Current Ratio | 1.51 |
| Quick Ratio | 1.39 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 8.30 |
Financial Efficiency
Return on equity (ROE) is 6.33% and return on invested capital (ROIC) is 4.59%.
| Return on Equity (ROE) | 6.33% |
| Return on Assets (ROA) | 3.11% |
| Return on Capital (ROIC) | 4.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.04 |
| Inventory Turnover | 22.84 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +136.61% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +136.61% |
| 50-Day Moving Average | 19.21 |
| 200-Day Moving Average | 10.64 |
| Relative Strength Index (RSI) | 51.48 |
| Average Volume (20 Days) | 137,408 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Alexandria New Medical Center had revenue of EGP 322.68 million and earned 13.02 million in profits. Earnings per share was 0.11.
| Revenue | 322.68M |
| Gross Profit | 91.03M |
| Operating Income | 15.46M |
| Pretax Income | 21.19M |
| Net Income | 13.02M |
| EBITDA | 26.04M |
| EBIT | 15.46M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
| Cash & Cash Equivalents | 40.09M |
| Total Debt | n/a |
| Net Cash | 40.09M |
| Net Cash Per Share | 0.32 |
| Equity (Book Value) | 212.53M |
| Book Value Per Share | 1.78 |
| Working Capital | 54.56M |
Cash Flow
In the last 12 months, operating cash flow was 31.33 million and capital expenditures -37.91 million, giving a free cash flow of -6.58 million.
| Operating Cash Flow | 31.33M |
| Capital Expenditures | -37.91M |
| Free Cash Flow | -6.58M |
| FCF Per Share | -0.05 |
Margins
Gross margin is 28.21%, with operating and profit margins of 4.79% and 4.04%.
| Gross Margin | 28.21% |
| Operating Margin | 4.79% |
| Pretax Margin | 6.57% |
| Profit Margin | 4.04% |
| EBITDA Margin | 8.07% |
| EBIT Margin | 4.79% |
| FCF Margin | -2.04% |
Dividends & Yields
Alexandria New Medical Center does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.61% |
| Shareholder Yield | 5.61% |
| Earnings Yield | 0.51% |
| FCF Yield | -0.25% |
Stock Splits
The last stock split was on May 9, 2024. It was a forward split with a ratio of 8.
| Last Split Date | May 9, 2024 |
| Split Type | Forward |
| Split Ratio | 8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |